0001213900-22-029231.txt : 20220524 0001213900-22-029231.hdr.sgml : 20220524 20220524132340 ACCESSION NUMBER: 0001213900-22-029231 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220524 DATE AS OF CHANGE: 20220524 EFFECTIVENESS DATE: 20220524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neotx Holdings Ltd. CENTRAL INDEX KEY: 0001659794 IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-446781 FILM NUMBER: 22955466 BUSINESS ADDRESS: STREET 1: 2 PEKERIS STREET CITY: REHOVOT STATE: L3 ZIP: 7670202 BUSINESS PHONE: 97239125853 MAIL ADDRESS: STREET 1: 2 PEKERIS STREET CITY: REHOVOT STATE: L3 ZIP: 7670202 FORMER COMPANY: FORMER CONFORMED NAME: Predictive Therapeutics Ltd. DATE OF NAME CHANGE: 20151201 D 1 primary_doc.xml X0708 D LIVE 0001659794 Neotx Holdings Ltd. 2 PEKERIS ST. REHOVOT L3 ISRAEL 7670202 +972 3 912 5853 BERMUDA None Predictive Therapeutics Ltd. Corporation true Asher Nathan 2 Pekeris St. Rehovot L3 ISRAEL 7670202 Executive Officer Director CEO and Director Robert Harow 2 Pekeris St. Rehovot L3 ISRAEL 7670202 Executive Officer Director CFO, COO and Director Roger Kornberg 2 Pekeris St. Rehovot L3 ISRAEL 7670202 Director Paul Marinelli 2 Pekeris St. Rehovot L3 ISRAEL 7670202 Director J. Tomilson Hill 2 Pekeris St. Rehovot L3 ISRAEL 7670202 Director Seo-Yong Cho 2 Pekeris St. Rehovot L3 ISRAEL 7670202 Director Biotechnology Decline to Disclose 06b false 2022-05-05 false true true true true 0 44700000 44700000 0 Total offering amount represents the deemed value of Issuer's shares issued to InterX, Inc. shareholders in a merger, consisting of $4.7 million of common shares issued at closing, and $40 million of preferred shares to be issued post-closing. false 0 0 0 0 false Neotx Holdings Ltd. /s/ Robert Harow Robert Harow Director, CFO and COO 2022-05-24